Inelastic Compression Use in Primary Lymphedema

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-25
SponsorUniversity School of Physical Education, Krakow, Poland

About this trial

Primary lymphedema in children is a rare, chronic condition caused by congenital or inherited developmental abnormalities in the lymphatic system that lead to persistent fluid buildup and swelling. While there is no cure, early and regular intervention helps control swelling and allows children to lead active lives. While compression therapy (multilayer compression bandaging and compression garment use) is a standard of lymphedema treatment for adults clinical trials evaluating compression therapy specifically for children with primary lymphedema are severely limited. Management algorithms are heavily adopted from adults secondary lymphedema protocols. However the results obtained from clinical trials in adults cannot be directly extrapolated to children with primary lymphedema. Inelastic, short-stretch materials-is highly effective for treating children with primary lymphedema, but requires precise clinical caution to protect fragile pediatric skin. Dose-finding to establish safe and effective interface pressure threshold (measured in mmHg) appropriate for different age cohorts (e.g., infants under 2 years old, toddlers, and adolescents) is needed. Objective of the study is to assess efficacy, physical functioning, safety and adherence to compression therapy based on individually adapted (made to measure, MTM) compression garments (flat knit compression stockings) with medium pressure (23-32 mmHg, ccl2) in children and young adults with primary lymphedema during one and three months of maintenance therapy. The aim of this study is also verification if pressure and stiffness measured in vivo correlate with laboratory findings (compression garment in ccl2 delivered by manufacture) and whether there is a relationship between interface pressures under compression and limb volume measurements in children and young people. The compression garments will be selected individually on the basis of circumference measurements, taking during morning hours with detailed information how long to wear them (i.e. for about 10 hours each day) and will come from the same producer (Medi GmbH \& Co. Bayreuth, Germany). All physical activities are recommended while wearing compression garments.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

children with recognised primary lymphedema of limbs

age < 1 year and ≥ 25 year

positive Stemmer's sign

vascular malformation,

Disqualifiers

primary lymphedema in adults, age ≤ 26

secondary lymphedema

heart and kidney diseases

Trial design

Design model

Parallel

Treatments tested in this trial

  • Compression device with medium pressure (23-32 mmHg)

    Device

    Compression garment use with medium pressure during a day

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: I Group Children (under 12 years of age)Experimental treatment 1 intervention
Group B: II Group Young People (age 12-25 years)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Limb volume measurement

Assessement including limb volumes based on the circumferential measurements by a tape (every 4 cm proximal along both limbs) will be performed (3 times) before the intervention, and after one and three months in both groups. Calculation of limb segment volumes was carried out using a simplified frustum formula (summed truncated cone). The excess volume is the difference between the affected and unaffected limbs expressed in litres.

Time frame
From enrollment to the end of treatment at 3 months
2

The percentage reduction of the excess volume

The percentage reduction of the excess volume will be obtained as follows: (excess volume before treatment - excess volume after treatment) x 100/excess volume before treatment

Time frame
From enrollment to the end of treatment at 3 months
3

Body mass

weight in kg

Time frame
From enrollment to the end of treatment at 3 months
4

Height

height in meters

Time frame
From enrollment to the end of treatment at 3 months

Secondary outcomes

1

Dosage of compression therapy

Children with the help of their parents (caregivers) according to the International Compression Club Compression Questionnaire (ICC-CQ) - Patient' version will evaluate how many hours during daytime, how many hours at night use the compression

Time frame
During the first and three months
2

Application and removing of compression

Children with the help of their parents (caregivers) according to the International Compression Club Compression Questionnaire (ICC-CQ) - Patient' version will evaluate garment application and removing difficulties: easy donning, easy doffing in 11-point Likert-type NRS scale - from 'not able at all' to 'completely able')

Time frame
During the first and three months
3

Physical functioning in relation to compression therapy

Children with the help of their parents (caregivers) according to the International Compression Club Compression Questionnaire (ICC-CQ) - Patient' version will evaluate physical functioning in relation to compression: ability to move the limbs and walk in 11-point Likert-type scale - from 'not able at all' to 'completely able'

Time frame
During the first and three months
4

Compression therapy and comfort

Children with the help of their parents (caregivers) according to the International Compression Club Compression Questionnaire (ICC-CQ) - Patient' version will evaluate comfort in compression: feeling immediately after donning, feeling during daytime, feeling at night, putting clothes on compression garments, and the appearance of the garment (measured on an 11-point Likert-type scale)

Time frame
During the first and three months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: